A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

NCT07335588 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

652

Enrollment

INDUSTRY

Sponsor class

Conditions

Lichen Sclerosus

Interventions

DRUG: Delgocitinib
DRUG: Cream Vehicle

Sponsor

LEO Pharma